Treatment of cryptosporidium infections
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 1, 1998
Issued Date -
N/A
app pub date -
Nov 12, 1996
filing date -
Nov 12, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method of reducing symptoms associated with cryptosporidia infection in mammals including humans in which L. reuteri cells are administered to the mammal in an amount sufficient to reduce diarrhea in the animal to a normal level. Daily administration as soon as cryptosporidia infection symptom are observed optimizes results. The L. reuteri cells may also be administered prophylactically to a mammal before exposure to cryptosporidia. The cells may be administered suspended in a liquid or in dry form.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully